Evidence map›Paper›PMID 16113133›Full record

Trial reportArchives of disease in childhood2005

Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease.

K Størdal, G B Johannesdottir, B S Bentsen, P K Knudsen, K C L Carlsen, O Closs, M Handeland, H K Holm, L Sandvik

Open access · bronzeAbstract readClinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Archives of disease in childhood, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 5 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 5 syntheses or guidelines pooled it, 120 citations in OpenAlex.

  1. Guideline
  2. Pharmacological treatment of gastro-oesophageal reflux in children.The Cochrane database of systematic reviews · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pharmacological treatment of children with gastro-oesophageal reflux.The Cochrane database of systematic reviews · 2014
    Pooled it
  6. Trial
  7. Multi-Organ Dysfunction in Cerebral Palsy.Frontiers in pediatrics · 2021
    Review
  8. Review
  9. Article
  10. Gastroesophageal Reflux Disease.Pediatric clinics of North America · 2017
    Review
  11. Review
  12. Review
  13. Monitoring asthma in childhood: management-related issues.European respiratory review : an official journal of the European Respiratory Society · 2015
    Review
  14. Lung diffusion capacity in children with respiratory symptoms and untreated GERD.Medical science monitor : international medical journal of experimental and clinical research · 2014
    Article
  15. An update on paediatric asthma.European respiratory review : an official journal of the European Respiratory Society · 2012
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

K StørdalDept of Paediatrics, Østfold County Hospital, 1602 Fredrikstad, Norway. ketil.stoerdal@c2i.net
G B Johannesdottir
B S Bentsen
P K Knudsen
K C L Carlsen
O Closs
M Handeland
H K Holm
L Sandvik
Østfold Hospital Trust · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEpidemiological studies have shown an association between gastro-oesophageal reflux disease (GORD) and asthma, and oesophageal acid perfusion may cause bronchial constriction. However, no causative relation has been proven.

aimTo assess whether acid suppression would lead to reduced asthma symptoms in children with concomitant asthma and GORD.

methodsThirty eight children (mean age 10.8 years, range 7.2-16.8; 29 males) with asthma and a reflux index > or =5.0 assessed by 24 hour oesophageal pH monitoring were randomised to 12 weeks of treatment with omeprazole 20 mg daily or placebo. The groups were similar in age, gender, mean reflux index, and asthma severity. Primary endpoints were asthma symptoms (daytime wheeze, symptoms at night, in the morning, and during exercise) and quality of life (PAQLQ). Secondary endpoints were changes in lung function and the use of short acting bronchodilators. At the end of the study a repeated pH study was performed to confirm the efficacy of acid suppression.

resultsThe change in total symptom score did not differ significantly between the omeprazole and the placebo group, and decreased by 1.28 (95% CI -0.1 to 2.65) and 1.28 (95% CI -0.72 to 3.27) respectively. The PAQLQ score increased by 0.62 (95% CI 0.29 to 0.95) in the omeprazole group compared to 0.50 (95% CI 0.29 to 0.70) in the placebo group. Change in lung function and use of short acting bronchodilators were similar in the groups. The acid suppression was adequate (reflux index <5.0) under omeprazole treatment.

conclusionOmeprazole treatment did not improve asthma symptoms or lung function in children with asthma and GORD.

Indexed as

AdolescentAnti-Ulcer AgentsAsthmaChildEsophagusFemaleGastroesophageal RefluxHumansHydrogen-Ion ConcentrationMaleOmeprazoleQuality of LifeSeverity of Illness IndexSurveys and QuestionnairesTreatment OutcomeAnti-Ulcer AgentsOmeprazole

Identifiers

PMID16113133
PMCPMC1720585
OpenAlexW2159660788

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.